Multicenter Retrospective Study to Evaluate Compliance to Therapy and Drug Survival of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis in Routine Daily Clinical Practice

Trial Profile

Multicenter Retrospective Study to Evaluate Compliance to Therapy and Drug Survival of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis in Routine Daily Clinical Practice

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jul 2013

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms REMISSION II
  • Sponsors Roche
  • Most Recent Events

    • 23 May 2013 Planned end date changed from 1 Oct 2013 to 1 May 2013 as reported by ClinicalTrials.gov.
    • 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top